Reading the DVI OCTOBER 2013 NEWSLETTER, you would begin to know, the wealthy global vaccine conglomerates, with a history of over 70/years of profitable failures, have no idea, or fain ignorance, that non-toxic, quick responsive, natural cures and preventatives for dengue fever already exists today and have been around for many years past.
Welcome to the October issue of the DVI newsletter. The newsletter features Dr. Richard Mahoney in our Dengue Champion Spotlight, recognizing him for his input in the field of vaccine access and policy. (DVI, Oct 2013 – with emphasis added to quoted items in blue letters)
Dr. Scott Halstead summarizes the Consultation on Dengue Vaccines meeting organized by U.S. National Institutes of Health (NIH) and DVI, and Dr. Dagna Constenla presents the highlights of a workshop organized by the International Vaccine Access Center (IVAC) on financing of dengue vaccines. We bring you an interview with Dr. Duane Gubler, chairman of the newly launched Partnership for Dengue Control, about his vision for a new initiative that aims to integrate vaccines and vector control. Dr. Krisana Pengsaa provides an update on the International Training Course on Dengue that was organized by Mahidol University and the Thailand Chapter of the International Society of Tropical Pediatrics.
Teaching and getting world citizens to comply with proper area sanitation, vector, and rodent controls, even in middle class communities, have never been met with 100% compliance, even with the threats of civil enforcements. I point to my dear place of birth in making this statement, New York City, USA. I invite Dr. Krisana Pengsaa to prove me otherwise.
Finally, we want to highlight a couple of publications and upcoming events, including the Third International Conference on Dengue and Dengue Haemorrhagic Fever hosted in Bangkok on October 21-23, 2013. DVI will be in attendance, and will be hosting the Asia-Pacific Dengue Prevention Board and the Second Meeting of Countries Considering Early Dengue Vaccine Introduction, among other meetings. The Consolidated Points for Consideration, a document that provides a framework for countries interested in vaccine introduction, and the report of the April 2013 meeting among early adopter countries in Brazil are now available in our Resources section.
Acting Director for DVI
It is easy to see, the canvassing of countries over whom organizations possessed with the promotion of vaccines have influenced and swayed. Vaccines, still reported by some to be a distant 5/years from now, is what it is all about. Not present day known cures or preventatives which would leave the digging of many adult’s, children’s, and infant graves for far future dates and years. Where are the voices of pediatricians who know natural cures work? Where are you? Is there not one with a voice?
The poor, children and infants, as usual in social, political, and health initiatives, are but useful monetary pawns in the deadly dengue fever games they are playing on a global scale.
Dengue Champion Spotlight: Dr. Richard Mahoney
Dr. Richard Mahoney, PhD, head of Access and Policy for dengue vaccines at the International Vaccine Institute (IVI) between August 2005 and June 2013, is a U.S. scientist specializing in vaccine introduction in developing countries, an area that he has published extensively on. He has addressed financing strategies, manufacture (including cost of production), and access. He has also published extensively on intellectual property rights, including co-editing a major two-volume work on Intellectual Property Rights Management.
A Dengue Champion, dedicated to a project more than 70/year overdue. Where does Dr. Mahoney PhD direct his scientific credential expertise;
vaccine introduction in developing countries,
manufacture, cost of production
published extensively on intellectual property rights,
including co-editing a major two-volume work on Intellectual Property Rights Mangement. (reformatted for clarity)
For the past eight years, Dr. Mahoney served as the Coordinator for Policy and Access for DVI, where he demonstrated tireless devotion to building an enabling environment for the introduction and sustained use of dengue vaccines among the poor in developing countries.
“Rich has been devoted to the success of our Institute since even before its inception when he encouraged it as a part of the Children’s Vaccine Initiative,” said Dr. Christian Loucq, IVI’s Director General. “I would like to thank him for his immense contribution to the Institute including his efforts towards the success of the Dengue Vaccine Initiative.”
Dr. Mahoney has been a strong advocate for dengue vaccines in developing countries.
The true and under-recognized Dengue Champions would be health care professional advocates much like Doctor Sanath Hettige MBBS, DFM, MCGP, MD. Professionals like Dr. Hettige who laid the field ground work, leading to the 2012 scientific research and endorsements of papaya leaf extract being suitable as a home cure for dengue.
We are intelligent enough to know, which of the gentlemen mentioned about have had direct hands on experience to save the lives of adults, children and infants on a global basis. 70/years and vaccines don’t work. Papaya leaf extract was working even before Dr. Hettige managed to bring it to the attention of the editor of the British Medical Journal.
In conclusion, Dr. Mahoney’s great contribution to DVI was keeping the concept of vaccine access on center stage. His focus on vaccine access for low- and middle-income countries helped DVI generate 11 (2005-2013) peer-reviewed publications on vaccine access. In addition, he led the efforts on publishing annual reports of the Dengue Prevention Board meetings from 2005. He drafted and co-led numerous grants awarded by the Bill & Melinda Gates Foundation (BMGF), as well as various other donors, to support DVI in its vaccine access work. For these contributions, DVI remains grateful to Dr. Mahoney and wishes him good luck in his future endeavors.
Dr. Mahoney may be contacted at firstname.lastname@example.org.
Health-care revolves around money. The over 70/years of failings of the drug and vaccine conglomerates has been a profitable one. Tax payers through their governments have shouldered a big portion of the expense to the dengue fever research failures alive and financial rewarding for all top tier levels in this destructive game using the world citizens as pawns.
The extensive posting of quotes, reformatting, and emphasis added was done in the publics interest- the right to know truth. /Nicasio Martinez (by all means, read for yourselves the whole of the DVI OCTOBER 2013 NEWSLETTER.
Alert– for accredited scientific studies and research by institutions and individuals, clicking on the following link is a must— papayaleaves.wordpress.com
About PLXC-CTC Dengue Remedies
Let the sunshine in,/Nicasio Martineznm
Truth is a gem you have to search out, deeply and far beyond readily available institutions that assail your ears, eyes, thoughts, feelings, and emotions.
Disclaimer: As a Great-grandfather family webmaster, what I share should never be accepted as being medical advice, merely a sharing of easily re–searchable links for the purpose of educational sharing in the public interest.
You should research for yourself and make your best intelligent decisions— even before or after consulting with medical professionals who have earned your trust. /Nicasio Martinez